News ArchivesRead News

Your Weekly Parkinson's News Update for the Week of 12.3.18

Monday December 03, 2018
New Parkinson's Drug Target Revealed
through Study of Fatty Acids
Medical Xpress
The human brain is rich in lipids: investigators studying Parkinson's have become increasingly interested in lipids. Both molecular and genetic studies have pointed to the disruption of the balance of the brain's lipids as a potentially critical contributor to Parkinson's. Anew study led by investigators from Brigham and Women's Hospital and Harvard Medical School has provided insights into the role of fatty acids and suggests that inhibiting a specific enzyme can protect against neurotoxicity. Their findings point to a novel therapeutic approach that could be developed to treat Parkinson's and some forms of Alzheimer's.
Essential Oil From Brazilian Plant Delays
Parkinson’s Impairment in Mouse Model
Parkinson's News Today
Eplingiella fruticosa, popularly known as alecrim de tabuleiro (or board rosemary), is a native Brazilian plant used as both an aromatic herb as well as as a medicinal plant in traditional medicine: "Treatment with the essential oil extract alone was found to delay the onset of motor impairment, as determined by onset and duration of catalepsy (behavior immobility) episodes. The addition of β-cyclodextrin enhanced this positive effect, shortening the duration of these episodes throughout treatment."
University of Alabama Recognized Nationally
for Parkinson's Research
ABC 3340 News
Awarded by the National Institutes of Health, UAB joins the ranks of eight other schools in the country dedicated to Parkinson's research. These schools serve as a collaborative network in researching Parkinson's. Over the next five years, the $10 million grant will fund UAB's research on the role of inflammation and immune response in the progression, which Standaert, the Chair of UAB's Department of Neurology says has not been studied enough.